The diagnostic value of planar and spet scintimammography in different age groups

Nuclear Medicine Communications

Volumn 18, Issue 8, 1997, Pages 710-718

  Becherer, A ^a   Helbich, T ^a   Staudenherz, A ^a   Jakesz, R ^a   Lehner, R ^a   Rudas, M ^a   Teleky, B ^a   Kletter, K ^a   Leitha, T ^a  

^a UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M;

ADULT; AGED; ARTICLE; BREAST; BREAST BIOPSY; BREAST CARCINOMA; DIAGNOSTIC ACCURACY; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MAMMOGRAPHY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

EID: 8544269375     PISSN: 01433636     EISSN: 14735628     Source Type: Journal    
DOI: 10.1080/00006231-199708000-00004     Document Type: Article

References (28)

1. Jensen OM, Esteve J, Moller H, Renard H. Cancer in the European Community and its member states. Eur J Cancer 1990; 26: 1167-1256.
2. Thurfjell EL, Lindgren JAA. Population-based mammography screening in Swedish clinical practice: Prevalence and incidence screening in Uppsala county. Radiology 1994; 193: 351-357.
3. Sickles EA, Filly RA, Callen PW. Benign breast lesions: Ultrasound detection and diagnosis. Radiology 1984; 151: 467-470.
4. Kubin E, Miller VE, Berland LL, Han SY, Koehler RE, Stanley RJ. I land-held real-time breast sonography. AIR 1985; 144: 623-627.
5. Hey wang-Koebrunner SH, Beck R. Contrast-enhanced MRI of the breast. Berlin: Springer-Verlag, 1990.
6. Kaiser W. MR mammography. Berlin: Springer-Verlag, 1993.
7. Lee VW, Sax EJ, McAneny DB et al. A complementary role for thallium-201 scintigraphy with mammography in the diagnosis of breast cancer. J Nucl Med 1993; 12: 2095-2100.
8. Waxman AD, Ramanna L, Memsic LD et al. Thallium scintigraphy in the evaluation of mass abnormalities of the breast. J Nucl Med 1993; 34: 18-23.
9. Aktolun C, Bayhan H, Kir M. Clinical experience with Tc-99m-MIBI imaging in patients with malignant tumours: Preliminary results and comparison with Tl-201. Clin Nucl Med 1992; 17: 171-176.
10. Burak Z, Argon M, Memis A et al. Evaluation of palpable breast masses with Tc-99m-MlBI: A comparative study with mammography and ultrasonography. Nucl Med Com-imni 1994; 15: 604-612.
11. Khalkhali I, Mena I, Jouanne E et al. Prone scintimammo-graphy in patients with suspicion of carcinoma of the breast. J Ant Coll Surg 1994; 178: 491-497.
12. Cariaggi MP, Bulgaresi P, Confortini M et al. Analysis of the causes of false negative cytology reports on breast cancer fine needle aspirates. Cytopathology 1995; 6: 156-161.
13. Ballo MS, Sneige N. Can core needle biopsy replace fine needle aspiration cytology in the diagnosis of palpable breast carcinoma? A comparative study of 124 women. Cancer 1996; 15: 773-777.
14. Nagaraj N, Waxman A, Ashok G et al. Comparison of SPECT and planar Tc-99m-sestamibi (MIBI) imaging in patients with carcinoma of the breast (abstract). J Nucl Med 1994; 35: 229P.
15. Nathan MA, Seabold JE, Barloon T et al. Planar is SPECT Tc-99m MIBI. Evaluation of suspicious breast lesions on mammography: Histologic correlation (abstract). J Nucl Med 1994; 35: 229P.
16. Becherer A, Helbich T, Staudenherz A, Leitha T. Scinti-mammography with technetium-99m-sestamibi: Planar scanning v SPECT (abstract). Eur J Nucl Med 1996; 23: S3.
17. Khalkhali I, Cutrone J, Mena I et al. Scintimammography: The complementary role of Tc-99m sestamibi prone breast imaging for the diagnosis of breast carcinoma. Radioloy 1995; 196: 421-626.
18. Taillefer R, Robidoux A, Lambert R, Turpin S, Laperriere J. Technetium-99m-sestamibi prone scintimammography to detect primary breast cancer and axillary lymph node involvement. J Nucl Med 1995; 36: 1758-1765.
19. Palmedo H, Schomburg A, Grünwald F, Mallmann P, Biersack H-J. Technetium-99m-MIBI scintimammography for suspicious breast lesions. J Nucl Med 1996; 37: 626-630.
20. Tiling R, Pechmann M, Sommer H, Moser R, Tatsch K, Hahn K. Does SPECT improve the diagnostic accuracy of planar scintimammography with sestamibi? (abstract). J Nucl Med 1996; 37: 252P.
21. Becherer A, Helbich T, Staudenherz A, Rudas M, Leitha T. Accuracy of scintimammography with UHR-SPET depends on patient age and lesion histology (abstract). J Nucl Med 1996; 37: 254P.
22. Bassett LW, Liu T-H, Giuliano AE, Gold RH. The prevalence of carcinoma in palpable vs impalpable mammo-graphically detected lesions. AfR 1991; 157: 21-24.
23. Moretti J-L, Azaloux H, Boisseron D, Kouyoumdjian J-C, Vilcoq J. Primary breast cancer imaging with technetium-99m sestamibi and its relation with P-glycoprotein overexpression. Eur J Nucl Med 1996; 23: 980-986.
24. Palmedo H, Griinwald F, Bender H et al. Scintimammography with Tc-99m methoxyisobutylnitrile: Comparison with mammography and magnetic resonance imaging. Eur J Nucl Med 1996; 23: 940-946.
25. Clifford EJ, Lug-Zamudio C. Scintimammography in the diagnosis of breast cancer. Am J Surg 1996; 172: 483-486.
26. Gilles R, Gamier C, Meingan P et al. Fibroadenomas of the breast: Histopathological/dynamic contrast-enhanced MR correlation. Eur J Radiol 1995; 5: 511-517.
27. Ibrahim RE, Sciotto CG, Weidner N. Pseudoangiomatous hyperplasia of mammary stroma: Some observations regarding its dinicopathologic spectrum. Cancer 1989; 63: 1154-1160.
28. Scopinaro F, Schillaci O, Scarpini M et al. Technetium-99m-MIBI: An indicator of breast cancer invasiveness. Eur j Nucl Med 1994; 21: 984-987.